BioCrossroads Archives - Page 3 of 8 - The Central Indiana Corporate Partnership

Indiana leads the U.S. in pharmaceutical exports

Raquel Bahamonde2023-03-02T14:39:58-05:00March 2, 2023|

INDIANAPOLIS (March 2, 2023) -- Indiana leads the United States in pharmaceutical exports, according to new data from the Indiana Business Research Center at the Indiana University Kelley School of Business. Life sciences exports have always been a strong area for the state. Indiana has been one of the top three states in exports for all life sciences products – pharmaceuticals, medical device, and agbiosciences -- for more than a decade. In 2022, $13 billion of these products were shipped all over the world. In addition, 2022 saw a record amount of venture capital raised by Indiana start-ups for the third straight year – increasing to $620 million, an increase of nearly $200 million from 2021. Other key indicators and statistics for 2022 include: The economic output of the state’s life sciences industry was $77 billion, driven by more than [...]

BioCrossroads 2022 Annual Report

Raquel Bahamonde2023-03-09T09:47:28-05:00March 2, 2023|

Download PDF

BioCrossroads President and CEO Patty Martin to step down

Raquel Bahamonde2023-02-14T10:01:05-05:00February 14, 2023|

INDIANAPOLIS (Feb. 14, 2023) —BioCrossroads announced today that Patty Martin, president and CEO, has decided to step down from the organization. Martin, who is an ardent and passionate catalyst and connector for the life sciences in Indiana, will continue her engagement with the life sciences industry in the private sector. “Patty’s energy and passion have been felt throughout Indiana’s life sciences sector over the last four years,” said BioCrossroads Board Chair Dan Peterson and vice president of Government and Industry Affairs, Cook Group. “Her guidance and leadership have been especially critical as BioCrossroads reached a significant milestone with their 20th anniversary in 2022. As we look toward the future of the organization, the foundation she laid will continue to support new and exciting opportunities for the sector.” Martin advanced the important work of BioCrossroads through its collaborative, investment, and programming [...]

IBJ: Indiana Life Sciences Companies Raise Record $620M in 2022

Raquel Bahamonde2023-01-24T09:15:14-05:00January 24, 2023|

A recent article in the Indianapolis Business Journal by reporter John Russell, shows that Indiana’s healthcare and life sciences sector, often hailed as a key driver of the state’s economy, landed a record $619.8 million in venture funding last year, a hefty increase over the previous record, set a year earlier. Data provided by CICP's life sciences initiative BioCrossroads also shows that the amount of funding raised is 43% larger than the previous record of $433 million, set in 2021. According to the story, thirty-seven companies signed 40 deals last year for venture funding, for an average deal amount of $15.5 million. That is an improvement from the year before, when 39 companies signed deals worth an average amount of $11.1 million. [READ MORE] (Sources: Indianapolis Business Journal, BioCrossroads)

New report tracks 20 years of BioCrossroads and life sciences industry’s success

Raquel Bahamonde2022-10-06T13:41:14-04:00October 6, 2022|

INDIANAPOLIS (Oct. 6, 2022) – Today, BioCrossroads released a new report from TEConomy that follows the impact of BioCrossroads and Indiana’s life sciences sector over the last two decades -- BioCrossroads and the Indiana Life Sciences Ecosystem: Tracking Two Decades of Progress and Charting a Path for Sustained Success. The study highlights statistics that include the life sciences sector’s outperformance of Indiana’s economy since 2001 and outsized portion of total new jobs in the state over the past two decades. The report points out that “over the course of the next decade, it is expected that the life sciences will remain a key strategic driver of economic development in Indiana.” Although the life sciences represented just over 2% of the state’s total jobs in 2020, they contributed 23.7% net new jobs from 2001 to 2020. Of the nearly 50,000 new [...]

BioCrossroads and the Indiana Life Sciences Ecosystem: Tracking Two Decades of Progress and Charting a Path for Sustained Success

Raquel Bahamonde2022-11-14T10:15:48-05:00October 6, 2022|

Download PDF

BioCrossroads Honors Life Sciences Innovators in Indiana

Raquel Bahamonde2022-09-26T08:43:51-04:00September 26, 2022|

In an effort to recognize and honor some of the people leading the way and making significant contributions to the life sciences sector, our initiative BioCrossroads created the August M. Watanabe Life Sciences Champion of the Year Award to shine a light on innovation and growth in the state and recognize those whose impactful contributions have helped lead the sector to national prominence. This compilation is a look back at the trailblazers selected for this award over the years. [READ MORE] (Source: BioCrossroads)

Nora Doherty recognized as 2022 Watanabe Life Sciences Champion for strategic and meaningful impact on Indiana’s life sciences industry

Raquel Bahamonde2022-09-26T10:06:27-04:00September 22, 2022|

In addition to receiving the August M. Watanabe award, Doherty also received the Sagamore of the Wabash, the state's highest honor, from Indiana Gov. Eric J. Holcomb. INDIANAPOLIS (Sept. 22, 2022) — BioCrossroads’ Board of Directors today named former executive vice president of strategy of BioCrossroads and managing director of the Indiana Seed Funds, Nora Doherty, as the recipient of the 2022 August M. Watanabe Life Sciences Champion of the Year Award. The prestigious honor, named in tribute to BioCrossroads’ late Chairman August Watanabe, was given to Doherty at today’s Indiana Life Sciences Summit and 20th Anniversary CELLebration. Some of Doherty’s most significant achievements included developing a market for Indiana’s life sciences start-ups, including forming and managing funding mechanisms, engaging with universities and start-ups, and organizing new enterprises. Recognizing the need for early stage or seed stage capital, BioCrossroads, [...]

Manufacturing Readiness Grants Program 2022 Impact Report

Raquel Bahamonde2022-11-14T10:17:01-05:00September 9, 2022|

Download PDF

BioCrossroads announces 23 PAIR (Promising Achievers in Innovation and Research) winners

Raquel Bahamonde2022-08-24T07:44:36-04:00August 24, 2022|

INDIANAPOLIS (August 24, 2022) -- BioCrossroads today announced the winners of its inaugural 23 PAIR (Promising Achievers in Innovation and Research), a new recognition program that celebrates and promotes the state’s next generation of life sciences leaders. Award winners have exhibited significant industry or academic impact and success and are in the early stages of their careers. “People are such a critical component of Indiana’s life sciences industry, and we’re thrilled to recognize some incredibly talented Hoosiers for their work,” said Lori LeRoy, executive vice president of communications for BioCrossroads. “Our inaugural group of winners is already making their marks in the life sciences industry whether it’s directing clinical trials, performing groundbreaking research, communicating information, developing IT protocols, or analyzing data.” 2022 23 PAIR WINNERS: Carly Streicher Labcorp Drug Development Casey Lillibridge Inotiv Daniel Sheik Amplified Sciences Duchess Adjei Beckman [...]

MAIN MENU

IMPORTANT LINKS

INITIATIVES